ResMed [RMD] vs Intuitive Surgical [ISRG] Detailed Stock Comparison

ResMed

Intuitive Surgical
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: ResMed wins in 15 metrics, Intuitive Surgical wins in 4 metrics, with 0 ties. ResMed appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | ResMed | Intuitive Surgical | Better |
---|---|---|---|
P/E Ratio (TTM) | 29.26 | 63.00 | ResMed |
Price-to-Book Ratio | 6.83 | 9.08 | ResMed |
Debt-to-Equity Ratio | 14.27 | 0.00 | Intuitive Surgical |
PEG Ratio | 0.97 | 2.59 | ResMed |
EV/EBITDA | 21.73 | 49.26 | ResMed |
Profit Margin (TTM) | 27.22% | 28.51% | Intuitive Surgical |
Operating Margin (TTM) | 33.87% | 30.47% | ResMed |
EBITDA Margin (TTM) | 33.87% | 30.47% | ResMed |
Return on Equity | 25.86% | 16.04% | ResMed |
Return on Assets (TTM) | 14.02% | 9.02% | ResMed |
Free Cash Flow (TTM) | $1.65B | $1.30B | ResMed |
Dividend Yield | 0.63% | N/A | N/A |
1-Year Return | 16.99% | -7.24% | ResMed |
Price-to-Sales Ratio (TTM) | 7.93 | 17.73 | ResMed |
Enterprise Value | $40.43B | $156.94B | Intuitive Surgical |
EV/Revenue Ratio | 7.86 | 17.16 | ResMed |
Gross Profit Margin (TTM) | 60.84% | 66.31% | Intuitive Surgical |
Revenue per Share (TTM) | $35 | $26 | ResMed |
Earnings per Share (Diluted) | $9.52 | $7.18 | ResMed |
Beta (Stock Volatility) | 0.83 | 1.61 | ResMed |
ResMed vs Intuitive Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
ResMed | 1.00% | 3.81% | 0.69% | 9.74% | 32.10% | 23.15% |
Intuitive Surgical | -0.59% | 2.38% | -4.32% | -15.90% | -3.00% | -14.19% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
ResMed | 16.99% | 32.88% | 55.64% | 398.02% | 790.72% | 1,394.32% |
Intuitive Surgical | -7.24% | 145.65% | 79.24% | 765.95% | 1,346.41% | 5,952.36% |
News Based Sentiment: ResMed vs Intuitive Surgical
ResMed
News based Sentiment: MIXED
October was a mixed month for ResMed, with positive insider activity and a new product launch offset by a significant trade investigation. While the insider transactions suggest confidence, the Commerce Department probe introduces substantial uncertainty, making it a moderately important month for investors.
Intuitive Surgical
News based Sentiment: POSITIVE
Intuitive Surgical demonstrated strong financial performance in Q2 2025, coupled with significant product innovation and regulatory approvals. While analyst price targets were mixed, the overall sentiment remains positive, supported by a 'Moderate Buy' consensus and increased institutional holdings, suggesting continued growth potential.
Performance & Financial Health Analysis: ResMed vs Intuitive Surgical
Metric | RMD | ISRG |
---|---|---|
Market Information | ||
Market Cap | $40.79B | $163.30B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 873,960 | 2,417,000 |
90 Day Avg. Volume | 959,880 | 2,455,233 |
Last Close | $281.38 | $449.69 |
52 Week Range | $199.92 - $293.81 | $425.00 - $616.00 |
% from 52W High | -4.23% | -27.00% |
All-Time High | $301.34 (Sep 06, 2021) | $616.00 (Jan 20, 2025) |
% from All-Time High | -6.62% | -27.00% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.10% | 0.21% |
Quarterly Earnings Growth | 0.30% | 0.25% |
Financial Health | ||
Profit Margin (TTM) | 0.27% | 0.29% |
Operating Margin (TTM) | 0.34% | 0.30% |
Return on Equity (TTM) | 0.26% | 0.16% |
Debt to Equity (MRQ) | 14.27 | 0.00 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $40.77 | $49.79 |
Cash per Share (MRQ) | $8.26 | $14.86 |
Operating Cash Flow (TTM) | $1.75B | $2.83B |
Levered Free Cash Flow (TTM) | $1.21B | $1.82B |
Dividends | ||
Last 12-Month Dividend Yield | 0.63% | N/A |
Last 12-Month Dividend | $1.59 | N/A |
Valuation & Enterprise Metrics Analysis: ResMed vs Intuitive Surgical
Metric | RMD | ISRG |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 29.26 | 63.00 |
Forward P/E | 27.07 | 57.55 |
PEG Ratio | 0.97 | 2.59 |
Price to Sales (TTM) | 7.93 | 17.73 |
Price to Book (MRQ) | 6.83 | 9.08 |
Market Capitalization | ||
Market Capitalization | $40.79B | $163.30B |
Enterprise Value | $40.43B | $156.94B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 7.86 | 17.16 |
Enterprise to EBITDA | 21.73 | 49.26 |
Risk & Other Metrics | ||
Beta | 0.83 | 1.61 |
Book Value per Share (MRQ) | $40.77 | $49.79 |
Financial Statements Comparison: ResMed vs Intuitive Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | RMD | ISRG |
---|---|---|
Revenue/Sales | $1.35B | $2.44B |
Cost of Goods Sold | $527.93M | $822.10M |
Gross Profit | $820.07M | $1.62B |
Research & Development | $86.44M | $313.30M |
Operating Income (EBIT) | $456.57M | $743.40M |
EBITDA | $532.89M | $898.70M |
Pre-Tax Income | $458.05M | $832.10M |
Income Tax | $78.35M | $167.90M |
Net Income (Profit) | $379.71M | $664.20M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | RMD | ISRG |
---|---|---|
Cash & Equivalents | $1.21B | $2.57B |
Total Current Assets | $3.51B | $7.66B |
Total Current Liabilities | $1.02B | $1.54B |
Long-Term Debt | $811.41M | N/A |
Total Shareholders Equity | $5.97B | $17.21B |
Retained Earnings | $6.08B | $7.14B |
Property, Plant & Equipment | $288.62M | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | RMD | ISRG |
---|---|---|
Operating Cash Flow | $441.40M | $833.10M |
Capital Expenditures | $-30.59M | $-116.60M |
Free Cash Flow | $504.99M | $465.00M |
Debt Repayment | $-5.00M | N/A |
Common Stock Repurchase | $-100.01M | N/A |
Short Interest & Institutional Ownership Analysis
Metric | RMD | ISRG |
---|---|---|
Shares Short | 8.65M | 5.72M |
Short Ratio | 8.77 | 2.50 |
Short % of Float | 0.07% | 0.02% |
Average Daily Volume (10 Day) | 873,960 | 2,417,000 |
Average Daily Volume (90 Day) | 959,880 | 2,455,233 |
Shares Outstanding | 146.39M | 356.60M |
Float Shares | 145.48M | 356.30M |
% Held by Insiders | 0.01% | 0.01% |
% Held by Institutions | 0.65% | 0.89% |
Dividend Analysis & Yield Comparison: ResMed vs Intuitive Surgical
Metric | RMD | ISRG |
---|---|---|
Last 12-Month Dividend | $1.59 | N/A |
Last 12-Month Dividend Yield | 0.63% | N/A |
3-Year Avg Annual Dividend | $1.60 | N/A |
3-Year Avg Dividend Yield | 0.23% | N/A |
3-Year Total Dividends | $4.79 | N/A |
Ex-Dividend Date | Feb 13, 2025 | N/A |